Search Results - "Kapetanovic, M."

Refine Results
  1. 1

    Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats by Kapetanovic, Izet M., Muzzio, Miguel, Huang, Zhihua, Thompson, Thomas N., McCormick, David L.

    Published in Cancer chemotherapy and pharmacology (01-09-2011)
    “…Purpose Resveratrol (3,5,4′-trihydroxy- trans -stilbene) is a naturally occurring polyphenol with a broad range of possible health benefits, including…”
    Get full text
    Journal Article
  2. 2

    Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis by Kapetanovic, M. C., Saxne, T., Sjöholm, A., Truedsson, L., Jönsson, G., Geborek, P.

    Published in Rheumatology (Oxford, England) (01-01-2006)
    “…Objective. To compare antibody responses to 23-valent pneumococcal vaccine (Pneumovax®) in controls and patients with established rheumatoid arthritis (RA)…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control? by Roseman, C, Wallman, J K, Jöud, A, Schelin, Mec, Einarsson, J T, Lindqvist, E, Lampa, J, Kapetanovic, M C, Olofsson, T

    “…While considerable focus has been placed on pain due to inflammation in psoriatic arthritis (PsA), less is reported on pain despite inflammation control. Here,…”
    Get full text
    Journal Article
  5. 5

    Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register by Karlsson, J. A., Kristensen, L. E., Kapetanovic, M. C., Gülfe, A., Saxne, T., Geborek, P.

    Published in Rheumatology (Oxford, England) (01-04-2008)
    “…Objectives. To study treatment response rates of RA patients undergoing second- and third-line anti-TNF therapy and to identify baseline predictors of response…”
    Get full text
    Journal Article
  6. 6

    Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis by Nagel, J., Jönsson, G., Nilsson, J-Å., Manuswin, C., Englund, M., Saxne, T., Kapetanovic, M.C.

    Published in Vaccine (09-01-2023)
    “…To examine rates of serious pneumococcal infections up to 10 years after vaccination with 7-valent conjugated pneumococcal vaccine (PCV7) in patients with…”
    Get full text
    Journal Article
  7. 7

    Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register by Kristensen, L. E., Kapetanovic, M. C., Gülfe, A., Söderlin, M., Saxne, T., Geborek, P.

    Published in Rheumatology (Oxford, England) (01-04-2008)
    “…Objective. To identify factors predicting response to first TNF blocking treatment course in patients with established RA with a special focus on gender…”
    Get full text
    Journal Article
  8. 8

    Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement by Kapetanovic, M C, Lindqvist, E, Saxne, T, Eberhardt, K

    Published in Annals of the rheumatic diseases (01-10-2008)
    “…To study the prevalence of orthopaedic surgery and to evaluate possible predictive factors for large joint replacements in patients with early rheumatoid…”
    Get more information
    Journal Article
  9. 9

    Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine by Nagel, J, Saxne, T, Geborek, P, Bengtsson, A A, Jacobsen, S, Svaerke Joergensen, C, Nilsson, J-Å, Skattum, L, Jönsen, A, Kapetanovic, M C

    Published in Lupus (01-09-2017)
    “…Background/purpose The objective of this study was to explore the impact of systemic lupus erythematosus and belimumab given in addition to standard of care…”
    Get full text
    Journal Article
  10. 10

    The use of anthropometric measures in the prediction of incident gout: results from a Swedish community-based cohort study by Wändell, P, Andreasson, A, Hagström, H, Kapetanovic, MC, Carlsson, AC

    Published in Scandinavian journal of rheumatology (04-07-2019)
    “…Objectives: To study associations between different anthropometric measures and incident gout, and to find the best predictive measure. Method: We used the…”
    Get full text
    Journal Article
  11. 11

    Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients by Kapetanovic, M. C., Saxne, T., Nilsson, J.-Å., Geborek, P.

    Published in Rheumatology (Oxford, England) (01-04-2007)
    “…Objectives. To compare serological response to influenza vaccine in patients with long-standing rheumatoid arthritis (RA) treated with tumour necrosis factor…”
    Get full text
    Journal Article
  12. 12

    Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden by Gulfe, A, Kapetanovic, MC, Kristensen, LE

    Published in Scandinavian journal of rheumatology (01-11-2014)
    “…Objectives: To evaluate the efficacy and drug survival of anti-tumour necrosis factor (anti-TNF) therapy in non-radiographic axial spondyloarthritis (nr-axSpA)…”
    Get full text
    Journal Article
  13. 13

    Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts by de Rooy, D P C, van Nies, J A B, Kapetanovic, M C, Kristjansdottir, H, Andersson, M L E, Forslind, K, van der Heijde, D M F M, Gregersen, P K, Lindqvist, E, Huizinga, T W J, Gröndal, G, Svensson, B, van der Helm-van Mil, A H M

    Published in Annals of the rheumatic diseases (01-07-2014)
    “…Smoking is a risk factor for the development of anti -citrullinated protein antibodies (ACPA) positive rheumatoid arthritis (RA). Whether smoking predisposes…”
    Get more information
    Journal Article
  14. 14

    Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s by Kapetanovic, MC, Lindqvist, E, Geborek, P, Saxne, T, Eberhard, K

    Published in Scandinavian journal of rheumatology (01-11-2011)
    “…Objective: To investigate the mortality rate and possible early predictive factors of mortality after 19-23 years in a cohort of patients with rheumatoid…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs by Kapetanovic, I.M, Crowell, J.A, Krishnaraj, R, Zakharov, A, Lindeblad, M, Lyubimov, A

    Published in Toxicology (Amsterdam) (16-06-2009)
    “…Abstract Standardized green tea extract was evaluated for exposure and toxicity in Beagle dogs following oral dosing by capsules. The main component…”
    Get full text
    Journal Article
  17. 17

    The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients by Nagel, J, Geborek, P, Saxne, T, Jönsson, G, Englund, M, Petersson, IF, Nilsson, J-Å, Kapetanovic, MC

    “…Objectives: To examine the risk of putative pneumococcal infections in adult arthritis patients on different anti-rheumatic drugs immunized with heptavalent…”
    Get full text
    Journal Article
  18. 18

    Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach by Kapetanovic, I.M.

    Published in Chemico-biological interactions (30-01-2008)
    “…It is generally recognized that drug discovery and development are very time and resources consuming processes. There is an ever growing effort to apply…”
    Get full text
    Journal Article
  19. 19
  20. 20